But there are also risks, and we hope these findings prompt discussion with people and their providers.” Many of the health benefits listed in the new paper are known. The U.S. Food and Drug ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

A new study, the first to catalogue these risks and benefits, confirmed that these drugs are associated with a lower risk of heart attack, stroke and other cardiovascular problems. People who took ...

Ph.D."Understanding the risks and limitations of this technology is essential to harnessing its potential in medicine." The study used an AI model known as GPT-4V (Generative Pre-trained ...

While these health benefits are well established, information is sparse on the drugs' effects across the body's organ systems. Now, scientists at Washington University School of Medicine in St ...

An observational study of 175 health outcomes using Veterans Affairs (VA) data for nearly 2 million individuals uncovered new insights about possible risks and benefits of GLP-1 receptor agonists.